Shortage Notice: Rythmodan (Disopyramide) 100mg Capsules

Shortage Notice: Rythmodan (Disopyramide) 100mg Capsules

July 9, 2019

Following our previous shortage announcement for Disopyramide 100mg and 150mg capsules Sanofi the manufacturers of Rythmodan (Disopyramide )100mg Capsules have released a Dear Healthcare Professional letter.

Sanofi has announced that due to manufacturing issues Rythmodan (Disopyramide )100mg Capsules will be out of stock until September 2019. To cover this period Sanofi has made arrangements to import unlicensed Italian stock of Ritmodan 100mg Capsules. Details can be found in the Dear Healthcare Professional letter including a link for a a UK approved PIL.

Should a prescriber wish you to dispense the import, prescriptions should be amended to read Ritmodan 100mg Capsules or annotated ‘specials/unlicensed’ to ensure correct reimbursement. All prescriptions for an import should be endorsed as follows and placed in the red separator:

  • Amount dispensed over pack size used;
  • Invoice price per pack size from which the order was supplied less any discount or rebate;
  • Importers’ MHRA licence number;
  • Batch number of the product supplied;
  • SP

If you have any questions or require additional information please contact Sanofi Medical Information Tel: 0845 372 7101 Email: 

Posted in: ,

More Latest News >

CPCS Frequently Asked Questions

With the Community Pharmacist Consultation Service (CPCS) now bedding in, below you will find a selection of questions about the...

CPCS: CPD opportunities

As announced in the 5-year CPCF agreement, NHS England & NHS Improvement and Health Education England (HEE) will use funding...